Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY308.00; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TAK Hot Sheet
Join SI Premium – FREE
Takeda Pharmaceutical Company Limited (NYSE: TAK) reported 1H EPS of JPY308.00. Revenue for the period came in at JPY2407 billion.
GUIDANCE:
Takeda Pharmaceutical Company Limited sees FY2026 EPS of JPY482.00. Takeda Pharmaceutical Company Limited sees FY2026 revenue of JPY4700 billion.
For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- FatPipe, Inc. (FATN) Reports Q3 EPS of $0.09
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
